CD44 and cholangiocarcinoma: While some studies, such as the large analysis by Padthaisong et al., have linked high expression of CD44 and its variant CD44v6 to poor prognosis and recurrence in CCA [19], our findings align more closely with other reports suggesting a lack of independent prognostic value for individual isoforms [18].